U
Braveheart Bio, Inc. BRVE
$27.03 $1.064.08% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2026 03/31/2025
Total Cash And Short-Term Investments 80.58M --
Total Receivables -- --
Inventory -- --
Prepaid Expenses 496.00K --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 81.07M --

Total Current Assets 81.07M --
Net Property, Plant & Equipment 736.00K --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 70.00K --
Total Assets 81.88M --

Total Accounts Payable 7.74M --
Total Accrued Expenses 1.89M --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 373.00K --
Total Finance Division Other Current Liabilities -- --
Total Other Current Liabilities -- --
Total Current Liabilities 10.00M --

Total Current Liabilities 10.00M --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases 294.00K --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 89.00K --
Total Liabilities 10.39M --

Common Stock & APIC 1.94M --
Retained Earnings -80.33M --
Treasury Stock & Other -- --
Total Common Equity -78.39M --

Preferred Stock Redeemable 124.21M --
Preferred Stock Non Redeemable 25.68M --
Preferred Stock Convertible -- --
Preferred Stock, Others -- --
Total Preferred Equity 149.89M --

Total Common Equity -78.39M --
Total Preferred Equity 149.89M --
Total Minority Interest -- --
Total Equity 71.49M --